| scholarly article | Q13442814 |
| P50 | author | Tomas C Bellamy | Q57065559 |
| P2093 | author name string | J Garthwaite | |
| C H Griffiths | |||
| L R James | |||
| P2860 | cites work | Nitric oxide: discovery and impact on clinical medicine | Q22003799 |
| Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme | Q24299059 | ||
| NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential | Q24656131 | ||
| Nitric oxide: physiology, pathophysiology, and pharmacology | Q26778243 | ||
| Vascular endothelial cells synthesize nitric oxide from L-arginine | Q28291036 | ||
| The shaping of nitric oxide signals by a cellular sink | Q28363196 | ||
| Cytochrome P450 oxidoreductase participates in nitric oxide consumption by rat brain | Q28564167 | ||
| Calcium signalling: dynamics, homeostasis and remodelling | Q29547635 | ||
| Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling | Q29615163 | ||
| Sub-second kinetics of the nitric oxide receptor, soluble guanylyl cyclase, in intact cerebellar cells | Q31552489 | ||
| "cAMP-specific" phosphodiesterase contributes to cGMP degradation in cerebellar cells exposed to nitric oxide. | Q31744682 | ||
| NO-independent regulatory site on soluble guanylate cyclase | Q32165040 | ||
| Regulation of store-operated calcium entry by calcium-independent phospholipase A2 in rat cerebellar astrocytes. | Q33257525 | ||
| Mammalian nitric oxide synthases | Q33631306 | ||
| Apocalmodulin | Q33676883 | ||
| Endogenous nitric oxide synthesis: biological functions and pathophysiology | Q33814359 | ||
| GLIA: listening and talking to the synapse | Q33938676 | ||
| Identification of the enzymatic mechanism of nitroglycerin bioactivation | Q34032459 | ||
| Glial calcium: homeostasis and signaling function | Q34455344 | ||
| Blocking NO synthesis: how, where and why? | Q35013972 | ||
| Nitric oxide-releasing drugs | Q35050581 | ||
| Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses | Q35084643 | ||
| Calmodulin is a subunit of nitric oxide synthase from macrophages | Q36231600 | ||
| Glutamate-mediated glial injury: mechanisms and clinical importance | Q36277315 | ||
| Concepts of neural nitric oxide-mediated transmission | Q37029494 | ||
| How calmodulin binds its targets: sequence independent recognition of amphiphilic alpha-helices | Q37921960 | ||
| Probing the presence of the ligand-binding haem in cellular nitric oxide receptors | Q39504233 | ||
| Nitric oxide/nucleophile complexes: a unique class of nitric oxide-based vasodilators | Q40384543 | ||
| Calmidazolium and arachidonate activate a calcium entry pathway that is distinct from store-operated calcium influx in HeLa cells | Q40558591 | ||
| The cross-talk between nitric oxide and Ca2+: a story with a complex past and a promising future | Q40885499 | ||
| Calmidazolium-induced rises in cytosolic calcium concentrations in Madin Darby canine kidney cells | Q40905843 | ||
| Reactions between nitric oxide, superoxide, and peroxynitrite: footprints of peroxynitrite in vivo | Q40945747 | ||
| Regulation of nitric oxide-responsive recombinant soluble guanylyl cyclase by calcium. | Q40951409 | ||
| Calmidazolium and other imidazole compounds affect steroidogenesis in Y1 cells: lack of involvement of the peripheral-type benzodiazepine receptor | Q41128926 | ||
| Calmidazolium is a potent stimulator of steroidogenesis via mechanisms not involving cyclic AMP, calcium or protein synthesis | Q41874475 | ||
| Superoxide-dependent consumption of nitric oxide in biological media may confound in vitro experiments | Q41974080 | ||
| Calcium-induced exposure of a hydrophobic surface on calmodulin | Q42244728 | ||
| YC-1, a novel activator of platelet guanylate cyclase | Q42275468 | ||
| Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one | Q42275867 | ||
| Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo | Q42562507 | ||
| Nitric oxide consumption through lipid peroxidation in brain cell suspensions and homogenates. | Q42816331 | ||
| A model for the regulation of the calmodulin-dependent enzymes erythrocyte Ca2+-transport ATPase and brain phosphodiesterase by activators and inhibitors | Q42868960 | ||
| Pharmacology of the nitric oxide receptor, soluble guanylyl cyclase, in cerebellar cells | Q43032725 | ||
| Guide to Receptors and Channels (GRAC), 3rd edition | Q43088119 | ||
| Inhibition of the type 1 inositol 1,4,5-trisphosphate-sensitive Ca2+ channel by calmodulin antagonists | Q43546859 | ||
| Nitric oxide activation of soluble guanylyl cyclase reveals high and low affinity sites that mediate allosteric inhibition by calcium. | Q43904218 | ||
| Regulation of neuronal nitric oxide and cyclic GMP formation by Ca2+ | Q44094890 | ||
| Small ligands modulating the activity of mammalian adenylyl cyclases: a novel mode of inhibition by calmidazolium | Q44329247 | ||
| A new and simple method for delivering clamped nitric oxide concentrations in the physiological range: application to activation of guanylyl cyclase-coupled nitric oxide receptors. | Q44674220 | ||
| A novel mechanism for the store-operated calcium influx pathway | Q44733406 | ||
| Purification of a Ca2+/calmodulin-dependent nitric oxide synthase from porcine cerebellum. Cofactor-role of tetrahydrobiopterin | Q45279535 | ||
| Dual regulation of cGMP formation by calcium in pancreatic acinar cells. | Q45978870 | ||
| Antioxidant effect of calmodulin antagonists in rat brain homogenate | Q48470843 | ||
| Sources and targets of nitric oxide in rat cerebellum | Q48505827 | ||
| Cyclic 3',5'-nucleotide phosphodiesterase. Demonstration of an activator. | Q48933876 | ||
| Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. | Q50917197 | ||
| Differentiation of the drug-binding sites of calmodulin | Q70174662 | ||
| Characteristics of the binding of phenoxybenzamine to calmodulin | Q70396537 | ||
| Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase | Q71239563 | ||
| Effect of calmidazolium analogs on calcium influx in HL-60 cells | Q73901614 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1454-1464 | |
| P577 | publication date | 2009-10-20 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Inhibition of nitric oxide-activated guanylyl cyclase by calmodulin antagonists | |
| P478 | volume | 158 |
| Q35623187 | Effects of 39 Compounds on Calmodulin-Regulated Adenylyl Cyclases AC1 and Bacillus anthracis Edema Factor |
| Q37559849 | Interactions of Bordetella pertussis adenylyl cyclase toxin CyaA with calmodulin mutants and calmodulin antagonists: comparison with membranous adenylyl cyclase I. |
| Q37697630 | Regulation of soluble guanylate cyclase by matricellular thrombospondins: implications for blood flow. |
| Q30503997 | Thrombospondin-1 and angiotensin II inhibit soluble guanylyl cyclase through an increase in intracellular calcium concentration |
Search more.